N348I in HIV-1 Reverse Transcriptase Can Counteract the Nevirapine-mediated Bias toward RNase H Cleavage during Plus-strand Initiation

This publication has 52 references indexed in Scilit:

• Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
  Antimicrobial Agents and Chemotherapy, 2010
• Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients
  Antiviral Research, 2009
• Mechanism by which a Glutamine to Leucine Substitution at Residue 509 in the Ribonuclease H Domain of HIV-1 Reverse Transcriptase Confers Zidovudine Resistance
  Biochemistry, 2008
• Slide into Action: Dynamic Shuttling of HIV Reverse Transcriptase on Nucleic Acid Substrates
  Science, 2008
• HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision
  Proceedings of the National Academy of Sciences, 2008
• Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms
  Journal of Biological Chemistry, 2008
• Dynamic binding orientations direct activity of HIV reverse transcriptase
  Nature, 2008
• Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors
  Virus Research, 2008
• Probing nonnucleoside inhibitor‐induced active‐site distortion in HIV‐1 reverse transcriptase by transient kinetic analyses
  Protein Science, 2007
• Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido-3′-deoxythymidine resistance
  Proceedings of the National Academy of Sciences, 2007